JAK2/STAT3 activation has been previously associated with the ability of TGF-β to induce pulmonary and liver fibrosis, epithelial-mesenchymal transition, and cancer cell migration/invasion (44–47). The gene discussed is STAT3; the disease is Hepatic fibrosis.